IMV acquired share capital Leja
7 May 2013

 

Lexence assisted IMV Technologies SA in the acquisition of the entire issued and outstanding share capital of Leja Products B.V.

 

Leja Products is active in developing and production of patented microscopical slides which are suitable for analysis of human and animal semen.

 

IMV is world leader on the market of repreduction biotechnologies. With the acquisition of Leja Products, IMV expands her knowledge and possibilities in her field.


Lawyer(s) involved: